Topline results from the latest in our series of psychedelics investor surveys. ∎ In late Q3’24, we distributed our Psychedelics Investor Survey. Prior to that, our last survey was back in Q4 2022, making this latest instalment long overdue.Indeed, lots has changed in that nearly two-year period…

Source

Previous articleDispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid
Next articleStandards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry